These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5757318)

  • 21. [Hemostasis in oral surgery].
    Amato R
    Ann Stomatol (Roma); 1971; 20(9):281-98. PubMed ID: 5290855
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of a child with a possible bleeding disorder.
    Sills RH
    N Y State J Med; 1986 Mar; 86(3):143-7. PubMed ID: 3458045
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality in hemostasis and thrombosis--part I.
    Favaloro EJ; Plebani M; Lippi G
    Semin Thromb Hemost; 2012 Sep; 38(6):549-52. PubMed ID: 22941783
    [No Abstract]   [Full Text] [Related]  

  • 24. [The determination of hemostatic defects in aeronautical personnel].
    Blundo G; Paolucci G; Rota P
    Riv Med Aeronaut Spaz; 1975; 38(4):427-32. PubMed ID: 9092063
    [No Abstract]   [Full Text] [Related]  

  • 25. A four point questionnaire: aiding discrimination with coagulation screening in epistaxis.
    Tjio E; Creagh D; Smith I
    Emerg Med J; 2013 May; 30(5):428. PubMed ID: 22886892
    [No Abstract]   [Full Text] [Related]  

  • 26. Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future.
    Zwaginga JJ; Sakariassen KS; Nash G; King MR; Heemskerk JW; Frojmovic M; Hoylaerts MF;
    J Thromb Haemost; 2006 Dec; 4(12):2716-7. PubMed ID: 16938128
    [No Abstract]   [Full Text] [Related]  

  • 27. Laboratory evaluation of hemostatic disorders.
    Hassouna HI
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1161-249. PubMed ID: 8294314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemorrhagic manifestations in patients with normal hemocoagulation and hemostasis tests].
    De Nicola P; Manara G; Guccione G; Cipolli PL
    Minerva Otorinolaringol; 1967; 17(11):183-6. PubMed ID: 5609604
    [No Abstract]   [Full Text] [Related]  

  • 29. Coagulation testing in pediatric patients: the young are not just miniature adults.
    Lippi G; Franchini M; Montagnana M; Guidi GC
    Semin Thromb Hemost; 2007 Nov; 33(8):816-20. PubMed ID: 18175287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many.
    Girolami A; Vettore S
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):484-5. PubMed ID: 19675419
    [No Abstract]   [Full Text] [Related]  

  • 31. New approaches for measuring coagulation.
    Barrowcliffe TW; Cattaneo M; Podda GM; Bucciarelli P; Lussana F; Lecchi A; Toh CH; Hemker HC; Béguin S; Ingerslev J; Sørensen B
    Haemophilia; 2006 Jul; 12 Suppl 3():76-81. PubMed ID: 16684000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Automatic interpretation of the hemostasis report. Preliminary note].
    Fernet P; Boneu B; Bouquet H; Bley J; Bierme R
    Nouv Presse Med; 1972 Apr; 1(15):1037-8. PubMed ID: 4553205
    [No Abstract]   [Full Text] [Related]  

  • 33. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?
    Cattaneo M
    J Thromb Haemost; 2004 Jun; 2(6):890-1. PubMed ID: 15140123
    [No Abstract]   [Full Text] [Related]  

  • 34. Bleeding disorders. Finding the cause.
    Schafer AI
    Hosp Pract (Off Ed); 1984 Nov; 19(11):88K, 88L, 88M passim. PubMed ID: 6436278
    [No Abstract]   [Full Text] [Related]  

  • 35. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Hajdenberg J
    J Thromb Haemost; 2004 Dec; 2(12):2282-3; author reply 2283-5. PubMed ID: 15613056
    [No Abstract]   [Full Text] [Related]  

  • 36. [Congenital disorders of hemostasis. Diagnosis and treatment].
    Rolović Z
    Bilt Hematol Transfuz; 1982; 10(2-3):101-8. PubMed ID: 6927290
    [No Abstract]   [Full Text] [Related]  

  • 37. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of graphic methods: thrombodynamoelastography, resonance thrombography and coagulography in the detection of hemostasis disorders in patients with liver cirrhosis].
    Rezaković D; Haracić M; Kurto J; Kamhi J; Borovac N; Dzirlo IJ
    Med Arh; 1985; 39(2-3):51-6. PubMed ID: 3917130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary hemostasis].
    Dechavanne M; Bryon PA; Thouverez JP; Viala JJ
    Lyon Med; 1972 Apr; 19():Suppl:100-2. PubMed ID: 4641425
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemostasis disorders in liver cirrhosis. 1. Pathogenesis, diagnosis].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 Apr; 100(14):626-30. PubMed ID: 7084848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.